GAITHERSBURG, Md.--(BUSINESS WIRE)--Calibrant Biosystems announced today that data generated by their GeminiTM proteomic platform technology regarding drug discovery and development for breast, brain, and ovarian cancer will be presented at the 2008 American Association for Cancer Research (AACR) annual meeting. The AACR annual meeting will take place in San Diego, California, April 12th-16th, 2008. All three submitted abstracts were accepted for presentation by Drs. Xueping Fang and Keija Zhao of Calibrant Biosystems and the University of Maryland, and are as follows:
